{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:12:33Z","timestamp":1787508753111,"version":"build-2736575974"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T00:00:00Z","timestamp":1626912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:p>Glioblastoma is the most frequent and aggressive brain cancer in adults. While precision medicine in oncology has produced remarkable progress in several malignancies, treatment of glioblastoma has still limited available options and a dismal prognosis. After first-line treatment with surgery followed by radiochemotherapy based on the 2005 STUPP trial, no significant therapeutic advancements have been registered. While waiting that genomic characterization moves from a prognostic\/predictive value into therapeutic applications, practical and easy-to-use approaches are eagerly awaited. Medical reports on the role of the ketogenic diet in adult neurological disorders and in glioblastoma suggest that nutritional interventions may condition outcomes and be associated with standard therapies. The acceptable macronutrient distribution of daily calories in a regular diet are 45\u201365% of daily calories from carbohydrates, 20\u201335% from fats, and 10\u201335% from protein. Basically, the ketogenic diet follows an approach based on low carbohydrates\/high fat intake. In carbohydrates starvation, body energy derives from fat storage which is used to produce ketones and act as glucose surrogates. The ketogenic diet has several effects: metabolic interference with glucose and insulin and IGF-1 pathways, influence on neurotransmission, reduction of oxidative stress and inflammation, direct effect on gene expression through epigenetic mechanisms. Apart from these central effects working at the synapsis level, recent evidence also suggests a role for microbiome and gut-brain axis induced by a ketogenic diet. This review focuses on rationales supporting the ketogenic diet and clinical studies will be reported, looking at future possible perspectives.<\/jats:p>","DOI":"10.3389\/fnut.2021.703392","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T10:46:12Z","timestamp":1626950772000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["A Root in Synapsis and the Other One in the Gut Microbiome-Brain Axis: Are the Two Poles of Ketogenic Diet Enough to Challenge Glioblastoma?"],"prefix":"10.3389","volume":"8","author":[{"given":"Liliana","family":"Montella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Sarno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Altucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Cioffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Sigona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Di Colandrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"De Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Marinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca Arianna","family":"Facchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando","family":"De Vita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Berretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"de Falco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Facchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"European organisation for research and treatment of cancer brain tumor and radiotherapy groups; national cancer institute of canada clinical trials group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"vdaa082","DOI":"10.1093\/noajnl\/vdaa082","article-title":"Characterizing benefit from temozolomide in MGMT promoter unmethylated and methylated glioblastoma: a systematic review and meta-analysis","volume":"2","author":"Alnahhas","year":"2020","journal-title":"Neurooncol Adv"},{"key":"B3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1200\/EDBK_175003","article-title":"Beyond alkylating agents for gliomas: quo vadimus?","volume":"37","author":"Puduvalli","year":"2017","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"B4","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3390\/ijms22020587","article-title":"Updated Insights on EGFR signaling pathways in glioma","volume":"22","author":"Oprita","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B5","doi-asserted-by":"crossref","DOI":"10.15586\/codon.glioblastoma.2017.ch1","article-title":"Chapter 1: Glioblastoma Genomics: a very complicated story","volume-title":"Glioblastoma","author":"Lombardi","year":"2017"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/1878-0261.12155","article-title":"Emerging functions of the EGFR in cancer","volume":"12","author":"Sigismund","year":"2018","journal-title":"Mol Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"114282","DOI":"10.1016\/j.bcp.2020.114282","article-title":"Therapeutic potential of targeting mitochondrial dynamics in cancer","volume":"182","author":"Rodrigues","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"B8","first-page":"8017","article-title":"Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts","volume":"50","author":"Bigner","year":"1990","journal-title":"Cancer Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1476-4598-10-26","article-title":"EGFR and EGFRvIII undergo stress- and EGFR kinase inhibitor-induced mitochondrial translocalization: a potential mechanism of EGFR-driven antagonism of apoptosis","volume":"10","author":"Cao","year":"2011","journal-title":"Mol Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.3390\/cancers13061198","article-title":"EGFRvIII promotes cell survival during endoplasmic reticulum stress through a reticulocalbin 1-dependent mechanism","volume":"13","author":"Gomez","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1038\/s41388-020-1199-2","article-title":"EGFR activates GDH1 transcription to promote glutamine metabolism through MEK\/ERK\/ELK1 pathway in glioblastoma","volume":"39","author":"Yang","year":"2020","journal-title":"Oncogene"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1158\/1078-0432.CCR-14-2425","article-title":"Kimmelman metabolic dependencies in RAS-driven cancers","volume":"21","author":"Alec","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"12924","DOI":"10.1074\/jbc.M110.138958","article-title":"Involvement of autophagy in oncogenic K-Ras-induced malignant cell transformation","volume":"286","author":"Kim","year":"2011","journal-title":"J Biol Chem"},{"key":"B14","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.cell.2012.01.058","article-title":"Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism","volume":"149","author":"Ying","year":"2012","journal-title":"Cell"},{"key":"B15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","article-title":"The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism","volume":"20","author":"Hoxhaj","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.3390\/cells9071725","article-title":"The tumor suppressor PTEN as molecular switch node regulating cell metabolism and autophagy: implications in immune system and tumor microenvironment","volume":"9","author":"Aquila","year":"2020","journal-title":"Cells"},{"key":"B17","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3389\/fendo.2018.00338","article-title":"PTEN: tumor suppressor and metabolic regulator","volume":"9","author":"Chen","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1093\/jmcb\/mjy070","article-title":"Tumor suppressor p53 and metabolism","volume":"11","author":"Liu","year":"2019","journal-title":"J Mol Cell Biol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1126\/science.1058079","article-title":"Cooperation and competition in the evolution of ATP-producing pathways","volume":"292","author":"Pfeiffer","year":"2001","journal-title":"Science"},{"key":"B20","doi-asserted-by":"publisher","first-page":"567","DOI":"10.2174\/1570159X14666160121115641","article-title":"Mitochondrial dysfunction in gliomas: pharmacotherapeutic potential of natural compounds","volume":"14","author":"Guntuku","year":"2016","journal-title":"Curr Neuropharmacol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.3390\/cancers12102819","article-title":"The warburg effect 97 years after its discovery","volume":"12","author":"Pascale","year":"2020","journal-title":"Cancers"},{"key":"B22","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.bbcan.2018.01.004","article-title":"The pro-tumorigenic effects of metabolic alterations in glioblastoma including brain tumor initiating cells","volume":"1869","author":"Libby","year":"2018","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s11060-014-1452-z","article-title":"Overexpression of fatty acid synthase in human gliomas correlates with the WHO tumor grade and inhibition with Orlistat reduces cell viability and triggers apoptosis","volume":"118","author":"Grube","year":"2014","journal-title":"J Neurooncol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"8767","DOI":"10.3390\/ijms21228767","article-title":"Effects of ketone bodies on brain metabolism and function in neurodegenerative diseases","volume":"21","author":"Jensen","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.wneu.2017.06.164","article-title":"Type 2 diabetes mellitus and glioblastoma multiforme-assessing risk and survival: results of a large retrospective study and systematic review of the literature","volume":"106","author":"Barami","year":"2017","journal-title":"World Neurosurg"},{"key":"B26","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/ijc.32337","volume":"146","author":"Seliger","year":"2020","journal-title":"Int J Cancer"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/s41416-018-0009-x","article-title":"Influence of obesity-related risk factors in the aetiology of glioma","volume":"118","author":"Disney-Hogg","year":"2018","journal-title":"Br J Cancer"},{"key":"B28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.clineuro.2018.05.020","article-title":"The impact of hyperglycemia on survival in glioblastoma: a systematic review and meta-analysis","volume":"170","author":"Lu","year":"2018","journal-title":"Clin Neurol Neurosurg"},{"key":"B29","doi-asserted-by":"publisher","first-page":"8501","DOI":"10.3390\/ijerph17228501","article-title":"Clinical risk and overall survival in patients with diabetes mellitus, hyperglycemia and glioblastoma multiforme. A review of the current literature","volume":"17","author":"Montemurro","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"B30","doi-asserted-by":"publisher","first-page":"23141","DOI":"10.18632\/oncotarget.8153","article-title":"The altered glucose metabolism in tumor and a tumor acidic microenvironment associated with extracellular matrix metalloproteinase inducer and monocarboxylate transporters","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1002\/ijc.22062","article-title":"High incidence of EMMPRIN expression in human tumors","volume":"119","author":"Riethdorf","year":"2006","journal-title":"Int J Cancer"},{"key":"B32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.semcancer.2018.09.002","article-title":"Epigenetic modulation of metabolism in glioblastoma","volume":"57","author":"Dong","year":"2019","journal-title":"Semin Cancer Biol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1194\/jlr.R046797","article-title":"Thematic review series: calorie restriction and ketogenic diets the ketogenic diet for the treatment of malignant glioma","volume":"56","author":"Woolf","year":"2015","journal-title":"J Lipid Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3390\/brainsci8080148","article-title":"The expanding role of ketogenic diet in adult neurological disorders","volume":"8","author":"McDonald","year":"2018","journal-title":"Brain Sci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"15529","DOI":"10.1038\/s41598-019-52112-w","article-title":"Leucine-rich diet induces a shift in tumour metabolism from glycolytic towards oxidative phosphorylation, reducing glucose consumption and metastasis in Walker-256 tumour-bearing rats","volume":"9","author":"Viana","year":"2019","journal-title":"Sci Rep"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e36197","DOI":"10.1371\/journal.pone.0036197","article-title":"The ketogenic diet is an effective adjuvant to radiation therapy for the treatment of malignant glioma","volume":"7","author":"Abdelwahab","year":"2012","journal-title":"PLoS ONE"},{"key":"B37","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s11940-008-0043-8","article-title":"The ketogenic diet: uses in epilepsy and other neurologic illnesses","volume":"10","author":"Bara\u00f1ano","year":"2008","journal-title":"Curr Treat Options Neurol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fcell.2017.00043","article-title":"Metabolic reprogramming in glioma","volume":"5","author":"Strickland","year":"2017","journal-title":"Front Cell Dev Biol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1093\/neuonc\/now088","article-title":"A ketogenic diet increases transport and oxidation of ketone bodies in RG2 and 9L gliomas without affecting tumor growth","volume":"18","author":"De Feyter","year":"2016","journal-title":"Neuro Oncol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"101453","DOI":"10.1016\/j.isci.2020.101453","article-title":"Glioblastoma utilizes fatty acids and ketone bodies for growth allowing progression during ketogenic diet therapy","volume":"23","author":"Sperry","year":"2020","journal-title":"iScience"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.3174\/ajnr.A6287","article-title":"Cerebral ketones detected by 3T MR spectroscopy in patients with high-grade glioma on an atkins-based diet","volume":"40","author":"Berrington","year":"2019","journal-title":"AJNR Am J Neuroradiol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.3892\/ijo.2014.2382","article-title":"ERGO: a pilot study of ketogenic diet in recurrent glioblastoma","volume":"44","author":"Rieger","year":"2014","journal-title":"Int J Oncol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.3390\/cancers12123549","article-title":"Maintenance of energy homeostasis during calorically restricted ketogenic diet and fasting-MR-spectroscopic insights from the ERGO2 trial","volume":"12","author":"Wenger","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fnut.2018.00011","article-title":"Investigating the ketogenic diet as treatment for primary aggressive brain cancer: challenges and lessons learned","volume":"5","author":"Schwartz","year":"2018","journal-title":"Front Nutr"},{"key":"B45","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11060-020-03417-8","article-title":"Ketogenic diets as an adjuvant therapy for glioblastoma (KEATING): a randomized, mixed methods, feasibility study","volume":"147","author":"Martin-McGill","year":"2020","journal-title":"J Neurooncol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40170-020-00230-9","article-title":"Treatment of glioblastoma multiforme with \u201cclassic\u201d 4:1 ketogenic diet total meal replacement","volume":"8","author":"Klein","year":"2020","journal-title":"Cancer Metab"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1758835919882584","article-title":"Ketogenic diet treatment as adjuvant to standard treatment of glioblastoma multiforme: a feasibility and safety study","volume":"11","author":"Van der Louw","year":"2019","journal-title":"Ther Adv Med Oncol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"8250","DOI":"10.18632\/oncotarget.14159","article-title":"Stattic and metformin inhibit brain tumor-initiating cells by reducing STAT3-phosphorylation","volume":"8","author":"Leidgens","year":"2017","journal-title":"Oncotarget"},{"key":"B49","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3390\/biology9090264","article-title":"An experimentally defined hypoxia gene signature in glioblastoma and its modulation by metformin","volume":"9","author":"Calvo Tard\u00f3n","year":"2020","journal-title":"Biology (Basel)"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e06558","DOI":"10.1016\/j.heliyon.2021.e06558","article-title":"The potential of metformin as an antineoplastic in brain tumors: a systematic review","volume":"7","author":"Takhwifa","year":"2021","journal-title":"Heliyon"},{"key":"B51","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nri3430","article-title":"Role of the gut microbiota in immunity and inflammatory disease","volume":"13","author":"Kamada","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/eji.201948354","article-title":"Gut microbiota alterations affect glioma growth and innate immune cells involved in tumor immunosurveillance in mice","volume":"50","author":"D'Alessandro","year":"2020","journal-title":"Eur J Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"21002","DOI":"10.1038\/s41598-020-77919-w","article-title":"Glioma and temozolomide induced alterations in gut microbiome","volume":"10","author":"Patrizz","year":"2020","journal-title":"Sci Rep"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.2147\/DDDT.S298261","article-title":"Temozolomide-induced changes in gut microbial composition in a mouse model of brain glioma","volume":"15","author":"Li","year":"2021","journal-title":"Drug Design Dev Ther"},{"key":"B55","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.trecan.2019.02.008","article-title":"The gut-brain axis, paving the way to brain cancer","volume":"5","author":"Mehrian-Shai","year":"2019","journal-title":"Trends Cancer"},{"key":"B56","doi-asserted-by":"publisher","first-page":"CNS57","DOI":"10.2217\/cns-2020-0007","article-title":"Glioma induced alterations in fecal short-chain fatty acids and neurotransmitters","volume":"9","author":"Dono","year":"2020","journal-title":"CNS Oncol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.molcel.2016.10.025","article-title":"Diet-microbiota interactions mediate global epigenetic programming in multiple host tissues","volume":"64","author":"Krautkramer","year":"2016","journal-title":"Mol Cell"},{"key":"B58","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.3390\/cancers13112810","article-title":"Neuro-signals from gut microbiota: perspectives for brain glioma","volume":"13","author":"D'Alessandro","year":"2021","journal-title":"Cancers"},{"key":"B59","doi-asserted-by":"publisher","first-page":"534","DOI":"10.3390\/genes10070534","article-title":"Ketogenic diet and microbiota: friends or enemies?","volume":"10","author":"Paoli","year":"2019","journal-title":"Genes (Basel)"},{"key":"B60","doi-asserted-by":"publisher","first-page":"6670","DOI":"10.1038\/s41598-018-25190-5","article-title":"Ketogenic diet enhances neurovascular function with altered gut microbiome in young healthy mice","volume":"8","author":"Ma","year":"2018","journal-title":"Sci Rep"},{"key":"B61","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s11154-019-09518-8","article-title":"Keto microbiota: a powerful contributor to host disease recovery","volume":"20","author":"Cabrera-Mulero","year":"2019","journal-title":"Rev Endocr Metab Disord"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.cell.2018.04.027","article-title":"The gut microbiota mediates the anti-seizure effects of the ketogenic diet","volume":"173","author":"Olson","year":"2018","journal-title":"Cell"},{"key":"B63","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1515\/revneuro-2020-0078","article-title":"A review on preventive role of ketogenic diet (KD) in CNS disorders from the gut microbiota perspective","volume":"32","author":"Rawat","year":"2020","journal-title":"Rev Neurosci"},{"key":"B64","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.3390\/nu11102393","article-title":"Food components and dietary habits: keys for a healthy gut microbiota composition","volume":"11","author":"Rinninella","year":"2019","journal-title":"Nutrients"},{"key":"B65","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s43018-020-00159-4","article-title":"Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities","volume":"2","author":"Garofano","year":"2021","journal-title":"Nat Cancer"},{"key":"B66","doi-asserted-by":"publisher","first-page":"e1752","DOI":"10.32113\/wcrj_202011_1752","article-title":"Complementary and alternative medicine awareness in cancer patients receiving chemotherapy","volume":"7","author":"Inci","year":"2020","journal-title":"WCRJ."},{"key":"B67","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3389\/fonc.2020.00594","article-title":"Physician attitudes and perceptions of complementary and alternative medicine (CAM): a multicentre Italian study","volume":"10","author":"Berretta","year":"2020","journal-title":"Front Oncol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"24401","DOI":"10.18632\/oncotarget.14224","article-title":"Use of complementary and alternative medicine (CAM) in cancer patients: an Italian multicenter survey","volume":"8","author":"Berretta","year":"2017","journal-title":"Oncotarget"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2021.703392\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T10:11:33Z","timestamp":1628158293000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2021.703392\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,22]]},"references-count":68,"alternative-id":["10.3389\/fnut.2021.703392"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2021.703392","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,22]]},"article-number":"703392"}}